Alan B. Sandler - 29 Feb 2024 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Robert Yang, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4
Filing time
04 Mar 2024, 16:40:32 UTC
Previous filing
23 Jan 2024
Next filing
17 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +55,000 $0.000000 55,000 29 Feb 2024 Common Stock 55,000 $4.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36th of the total shares monthly, beginning on March 29, 2024, subject to the Reporting Person's continued service to the Issuer on each vesting date.